Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$44.03 USD
-0.16 (-0.36%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $44.02 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO8/6/24 |
---|---|
Current Quarter | -0.70 |
EPS Last Quarter | -2.35 |
Last EPS Surprise | -0.43% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.45 |
Next Year | -2.46 |
EPS (TTM) | -4.63 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 28.60M | 31.83M | 121.41M | 184.00M |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 29.90M | 33.08M | 127.21M | 218.96M |
Low Estimate | 25.57M | 27.70M | 106.54M | 154.62M |
Year ago Sales | 19.22M | 22.50M | 77.43M | 121.41M |
Year over Year Growth Est. | 48.79% | 41.44% | 56.80% | 51.56% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.70 | -0.76 | -4.45 | -2.46 |
# of Estimates | 8 | 7 | 8 | 8 |
Most Recent Consensus | NA | NA | NA | -1.70 |
High Estimate | -0.60 | -0.56 | -3.95 | -1.70 |
Low Estimate | -0.80 | -1.27 | -4.82 | -3.69 |
Year ago EPS | -0.82 | -0.76 | -3.20 | -4.45 |
Year over Year Growth Est. | 14.63% | 0.00% | -39.06% | 44.75% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 2 |
Down Last 60 Days | 0 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.70 | -0.76 | -4.45 | -2.46 |
7 Days Ago | -0.70 | -0.76 | -4.45 | -2.46 |
30 Days Ago | -0.70 | -0.77 | -4.44 | -2.43 |
60 Days Ago | -0.70 | -0.77 | -4.44 | -2.43 |
90 Days Ago | -0.64 | -0.70 | -4.02 | -1.98 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.70 | -0.57 | -3.96 | -2.06 |
Zacks Consensus Estimate | -0.70 | -0.76 | -4.45 | -2.46 |
Earnings ESP | 0.00% | 25.42% | 10.94% | 16.29% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.35 | -0.70 | -0.76 | -0.82 | NA |
Estimate | -2.34 | -0.70 | -0.76 | -0.80 | NA |
Difference | -0.01 | 0.00 | 0.00 | -0.02 | -0.01 |
Surprise | -0.43% | 0.00% | 0.00% | -2.50% | -0.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more